Sort
1,049,261 grants matching “t cell”
SARS-CoV-2: Pathogenesis and Countermeasure Development
$2,585,920Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
University of New Mexico Interdisciplinary HPV Prevention Center
$2,585,878Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2009 · AI
The MIT Superfund Research Program: A Systems Approach for the Protection of Human Health from Hazardous Chemicals
$2,585,844Bevin P. Engelward · Massachusetts Institute Of Technology · P42 · FY2025 · ES
Targeted Bone Regeneration via Activation of Resident Stem Cells
$2,585,805Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Solute And Water Transport In Renal Epithelia
$2,585,694Mark Knepper · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Novel Therapies for Muco-Obstructive Lung Diseases
$2,585,676Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2015 · HL
Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Inf
$2,585,548Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2016 · AI
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease
$2,585,455Berislav V Zlokovic · University Of Southern California · P01 · FY2016 · AG
Aging as a Risk Factor and Target for Prevention of Liver Cancer
$2,585,444Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · AG
Oral Ciclopirox Treatment for Congenital Erythropoietic Porphyria.
$2,585,421Robert J Desnick · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · FD
Aging as a Risk Factor and Target for Prevention of Liver Cancer
$2,585,419Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
Program Project: Role of Innate Immunity in Atherosclerosis
$2,585,410Joseph L Witztum · University Of California, San Diego · P01 · FY2012 · HL
Mechanisms of sleep and sleep apnea
$2,585,120Clifford B Saper · Beth Israel Deaconess Medical Center · P01 · FY2024 · HL
Pharmacogenomics and Risk of Cardiovascular Disease
$2,584,979Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · U19 · FY2012 · HL
Improving Prediction of Drug Action
$2,584,732Dan M Roden · Vanderbilt University Medical Center · P50 · FY2017 · GM
PACIFIC NORTHWEST PROSTATE CANCER SPORE
$2,584,662Fred Hutchinson Cancer Research Center · P50 · FY2005 · CA
Regulation of Neuroligins and Effects on Synapse Number and Function
$2,584,574Katherine Roche · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Transplant Tolerance in Non-Human Primates
$2,584,553Christian P Larsen · Emory University · U19 · FY2017 · AI
CCR Collaborative Bioinformatics Resource
$2,584,114David Goldstein · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
GBV-C-mediated protection from AIDS in humans and GBV-C/SIV co-infected macaques
$2,583,983David H Oconnor · University Of Wisconsin-Madison · R01 · FY2016 · AI
Spore in Head and Neck Cancer
$2,583,916David Sidransky · Johns Hopkins University · P50 · FY2011 · DE
Host Pathogen Variation & TB Pathogenesis
$2,583,647Thomas R Hawn · University Of Washington · U19 · FY2024 · AI
Molecular Mechanisms Of Synaptic Transmission
$2,583,576Robert J Wenthold · Deafness & Other Communication Disorders · Z01 · FY2007 · DC
Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment
$2,583,394Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
EFRI CEE: Epigenetic Cell Reprogramming In Situ: A Novel Tool for Regenerative Engineering
$2,583,356Guillermo A Ameer · Northwestern University · · FY2018 · ENG